The use of intermittent itraconazole therapy for superficial mycotic infections: a review and update on the 'one week' approach.

[1]  H. Degreef,et al.  Short-term itraconazole versus terbinafine in the treatmentof superficial dermatomycosis of the glabrous skin(tinea corporis or cruris) , 2000 .

[2]  G. Marynissen,et al.  Safety of Itraconazole in Diabetic Patients , 1999, Dermatology.

[3]  B. Sigurgeirsson,et al.  Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis , 1999 .

[4]  Aditya K. Gupta,et al.  Itraconazole Oral Solution for the Treatment of Onychomycosis , 1998, Pediatric dermatology.

[5]  A. Gupta,et al.  Onychomycosis in children: prevalence and management. , 1998, Pediatric dermatology.

[6]  C. R. Daniel,et al.  Onychomycosis: strategies to reduce failure and recurrence. , 1998, Cutis.

[7]  R. Summerbell,et al.  Treatment of tinea capitis with itraconazole capsule pulse therapy , 1998 .

[8]  Gupta,et al.  Itraconazole oral solution for the treatment of tinea capitis , 1998, The British journal of dermatology.

[9]  B. Amichai,et al.  Adverse drug reactions of the new oral antifungal agents – terbinafine, fluconazole, and itraconazole , 1998, International journal of dermatology.

[10]  C. Choonhakarn,et al.  Cutaneous polyarteritis nodosa: a report of a case associated with melioidosis (Burkholderia pseudomallei) , 1998, International journal of dermatology.

[11]  J. Lambert,et al.  Oral treatment schedules for onychomycosis: a study of patient preference , 1998, International journal of dermatology.

[12]  Aditya K. Gupta,et al.  Itraconazole Pulse Therapy for Tinea Capitis: A Novel Treatment Schedule , 1998, Pediatric dermatology.

[13]  Groen,et al.  Itraconazole pulse therapy is effective in the treatment of Majocchi's granuloma: a clinical and pharmacokinetic evaluation and implications for possible effectiveness in tinea capitis , 1998, Clinical and experimental dermatology.

[14]  G. Ginter,et al.  An intermittent itraconazole 1‐week dosing regimen for the treatment of toenail onychomycosis in dermatological practice , 1998, Mycoses.

[15]  C. R. Daniel,et al.  Itraconazole for the treatment of onychomycosis. , 1998, International journal of dermatology.

[16]  Aditya K. Gupta,et al.  Oral antifungal agents for onychomycosis , 1998, The Lancet.

[17]  G. Levy,et al.  Short-term itraconazole versus terbinafine in the treatment of tinea pedis or manus. , 1998, International journal of dermatology.

[18]  Roberts,et al.  Subungual dermatophytoma complicating dermatophyte onychomycosis , 1998, The British journal of dermatology.

[19]  W. Liao,et al.  Small‐dose itraconazole pulse therapy in the treatment of onychomycosis , 1997, Mycoses.

[20]  P. Stoffels,et al.  Itraconazole pulse therapy for onychomycosis and dermatomycoses: an overview. , 1997, Journal of the American Academy of Dermatology.

[21]  N. Shear,et al.  Cytochrome P-450 3A: interactions with dermatologic therapies. , 1997, Journal of the American Academy of Dermatology.

[22]  W. Joseph.  Oral treatment options for onychomycosis. , 1997, Journal of the American Podiatric Medical Association.

[23]  B. Elewski.  The effect of toenail onychomycosis on patient quality of life , 1997, International journal of dermatology.

[24]  B. Elewski,et al.  Fungal infections in HIV-infected patients. , 1997, Seminars in cutaneous medicine and surgery.

[25]  T. Rantanen,et al.  An open-label, noncomparative, multicenter evaluation of fluconalone with or without urea nail pedicure for treatment of onychomycosis , 1997 .

[26]  R. Summerbell,et al.  Itraconazole pulse therapy is effective in the treatment of tinea capitis in children: an open multicentre study , 1997, The British journal of dermatology.

[27]  C. Crosti,et al.  Calcipotriol in psoriasis vulgaris: a controlled trial comparing betamethasone dipropionate + salicylic acid , 1997, International journal of dermatology.

[28]  J. Rosso.  Advances in the treatment of superficial fungal infections: focus on onychomycosis and dry tinea pedis. , 1997 .

[29]  M. Klausner,et al.  Effect of a Cola Beverage on the Bioavailability of Itraconazole in the Presence of H2 Blockers , 1997, Journal of clinical pharmacology.

[30]  H. Degreef,et al.  Itraconazole for the treatment of tinea pedis: a dosage of 400 mg/day given for 1 week is similar in efficacy to 100 or 200 mg/day given for 2 to 4 weeks. , 1997, Journal of the American Academy of Dermatology.

[31]  M. Bräutigam,et al.  Evaluation of 6 weeks treatment of terbinafine in tinea unguium in a double‐blind trial comparing 6 and 12 weeks therapy , 1997, The British journal of dermatology.

[32]  P. Jacqmin,et al.  The effect of coadministration of a cola beverage on the bioavailability of itraconazole in patients with acquired immunodeficiency syndrome , 1997 .

[33]  B. Piraccini,et al.  Uncommon clinical patterns of Fusarium nail infection: report of three cases , 1997, The British journal of dermatology.

[34]  B. Elewski,et al.  Onychomycosis in children: prevalence and treatment strategies. , 1997, Journal of the American Academy of Dermatology.

[35]  C. R. Daniel,et al.  A multicenter, placebo-controlled, double-blind study of intermittent therapy with itraconazole for the treatment of onychomycosis of the fingernail. , 1997, Journal of the American Academy of Dermatology.

[36]  T. Rantanen,et al.  A double‐blind, randomized study comparing itraconazole pulse therapy with continuous dosing for the treatment of toe–nail onychomycosis , 1997, The British journal of dermatology.

[37]  H. Degreef,et al.  Itraconazole therapy is effective for pedal onychomycosis caused by some nondermatophyte molds and in mixed infection with dermatophytes and molds: a multicenter study with 36 patients. , 1997, Journal of the American Academy of Dermatology.

[38]  A. Bonifaz,et al.  Itraconazole in onychomycosis: intermittent dose schedule , 1997, International journal of dermatology.

[39]  A. Gupta,et al.  Current management of onychomycosis. An overview. , 1997, Dermatologic clinics.

[40]  B. Piraccini,et al.  Onychomycosis due to Scopulariopsis brevicaulis: clinical features and response to systemic antifungals , 1996, The British journal of dermatology.

[41]  D. Greer.  Treatment of tinea capitis with itraconazole. , 1996, Journal of the American Academy of Dermatology.

[42]  N. Gregory.  Special patient populations: onychomycosis in the HIV-positive patient. , 1996, Journal of the American Academy of Dermatology.

[43]  P. Rich.  Special patient populations: onychomycosis in the diabetic patient. , 1996, Journal of the American Academy of Dermatology.

[44]  R. Odom.  New therapies for onychomycosis. , 1996, Journal of the American Academy of Dermatology.

[45]  G. Ginter.  Microsporum canis infections in children: results of a new oral antifungal therapy , 1996, Mycoses (Berlin).

[46]  J. Hickman.  A double-blind, randomized, placebo-controlled evaluation of short-term treatment with oral itraconazole in patients with tinea versicolor. , 1996, Journal of American Academy of Dermatology.

[47]  B. Piraccini,et al.  Treatment of dermatophyte nail infections: an open randomized study comparing intermittent terbinafine therapy with continuous terbinafine treatment and intermittent itraconazole therapy. , 1996, Journal of the American Academy of Dermatology.

[48]  R. Hay,et al.  The use of itraconazole in onychomycosis , 1996 .

[49]  G. Piérard,et al.  Antifungal pulse therapy for onychomycosis. A pharmacokinetic and pharmacodynamic investigation of monthly cycles of 1-week pulse therapy with itraconazole. , 1996, Archives of dermatology.

[50]  R. Baran,et al.  Lateral edge nail involvement indicates poor prognosis for treating onychomycosis with the new systemic antifungals. , 1996, Acta dermato-venereologica.

[51]  K. Ahn,et al.  EFFICACY AND TOLERABILITY OF ITRACONAZOLE IN PATIENTS WITH FINGERNAIL ONYCHOMYCOSIS: A 6-WEEK PILOT STUDY , 1995 .

[52]  D. Roseeuw,et al.  Pulse therapy with one-week itraconazole monthly for three or four months in the treatment of onychomycosis. , 1995, Cutis.

[53]  G. Piérard,et al.  Antifungal activity of itraconazole and terbinafine in human stratum corneum: a comparative study. , 1995, Journal of the American Academy of Dermatology.

[54]  JACQUES DECROIX.  TINEA PEDIS (MOCASSINTYPE) TREATED WITH ITRACONAZOLE , 1995, International journal of dermatology.

[55]  M. Cuétara,et al.  ITRACONAZOLE VERSUS GRISEOFULVIN IN THE TREATMENT OF TINEA CAPITIS: A DOUBLE‐BLIND RANDOMIZED STUDY IN CHILDREN , 1994, International journal of dermatology.

[56]  B. Elewski,et al.  Introduction: International Summit on Cutaneous Antifungal Therapy* , 1994 .

[57]  C. Elmets.  Management of common superficial fungal infections in patients with AIDS. , 1994, Journal of American Academy of Dermatology.

[58]  J. Leyden.  Tinea pedis pathophysiology and treatment. , 1994, Journal of the American Academy of Dermatology.

[59]  R. Hay.  Antifungal therapy of yeast infections. , 1994, Journal of the American Academy of Dermatology.

[60]  R. Pariser,et al.  Double-blind comparison of itraconazole and placebo in the treatment of tinea corporis and tinea cruris. , 1994, Journal of the American Academy of Dermatology.

[61]  B. Elewski.  Tinea capitis: itraconazole in Trichophyton tonsurans infection. , 1994, Journal of the American Academy of Dermatology.

[62]  N. Shear,et al.  Antifungal agents: an overview. Part II. , 1994, Journal of the American Academy of Dermatology.

[63]  Wishart Jm.  A double blind study of itraconazole vs griseofulvin in patients with tinea pedis and tinea manus. , 1994 .

[64]  M. Heenen,et al.  Clinical experience with short schedules of itraconazole in the treatment of tinea corporis and/or tinea cruris. , 1994, Dermatology.

[65]  D. Rigopoulos,et al.  Itraconazole in the treatment of tinea corporis and tinea cruris , 1993, Clinical and experimental dermatology.

[66]  G. Stein,et al.  Placebo-controlled trial of itraconazole for treatment of acute vaginal candidiasis , 1993, Antimicrobial Agents and Chemotherapy.

[67]  J. Perfect,et al.  Adverse Drug Reactions to Systemic Antifungals , 1992, Drug safety.

[68]  J. V. van Cutsem,et al.  Posttreatment itraconazole levels in the nail. New implications for treatment in onychomycosis. , 1992, Journal of the American Academy of Dermatology.

[69]  J W Taylor,et al.  Itraconazole in Antifungal Therapy , 1992, The Annals of pharmacotherapy.

[70]  K. Kohtamäki,et al.  Efficacy and safety of itraconazole in the long-term treatment of onychomycosis. , 1992, The Journal of antimicrobial chemotherapy.

[71]  F. Rongioletti,et al.  Treatment of onychomycosis with itraconazole. , 1992, The Journal of dermatological treatment.

[72]  J. Lachapelle,et al.  Itraconazole compared with griseofulvin in the treatment of tinea corporis/cruris and tinea pedis/manus: an interpretation of the clinical results of all completed double-blind studies with respect to the pharmacokinetic profile. , 1992, Dermatology.

[73]  R. Woestenborghs,et al.  Itraconazole penetrates the nail via the nail matrix and the nail bed—an investigation in onychomycosis , 1991, Clinical and experimental dermatology.

[74]  R. Arenas,et al.  Onychomycosis Treated with Itraconazole or Griseofulvin Alone with and without a Topical Antimycotic or Keratolytic Agent , 1991, International journal of dermatology.

[75]  G. Lubin,et al.  SAFETY ASPECTS OF ITRACONAZOLE THERAPY IN VAGINAL CANDIDOSIS, DERMATOMYCOSIS, AND ONYCHOMYCOSIS : A REVIEW , 1991 .

[76]  R. Hay,et al.  Itraconazole in the management of chronic dermatophytosis. , 1990, Journal of the American Academy of Dermatology.

[77]  A. Bonifaz,et al.  Itraconazole in common dermatophyte infections of the skin: fixed treatment schedules. , 1990, Journal of the American Academy of Dermatology.

[78]  J. Delescluse.  Itraconazole in tinea versicolor: a review. , 1990, Journal of the American Academy of Dermatology.

[79]  R. Legendre,et al.  Itraconazole in the treatment of tinea capitis. , 1990, Journal of the American Academy of Dermatology.

[80]  J. V. van Cutsem,et al.  Itraconazole in the treatment of superficial mycoses—a double‐blind study vs. placebo , 1990, Clinical and experimental dermatology.

[81]  J. Cutsem.  The In‐vitro Antifungal Spectrum of Itraconazole , 1989 .

[82]  J. Lachapelle,et al.  Double‐Blind Comparison of Itraconazole with Griseofulvin in the Treatment of Tinea Corporis and Tinea Cruris , 1989, International journal of dermatology.

[83]  E. Hecke,et al.  Double‐Blind Comparison of Itraconazole with Griseofulvin in the Treatment of Tinea Pedis and Tinea Manuum./Doppelblind‐Vergleich von Itraconazol mit Griseofulvin bei der Behandlung von Tinea pedis und Tinea manuum , 1988 .

[84]  R. Hay,et al.  An evaluation of itraconazole in the management of onychomycosis , 1988, The British journal of dermatology.

[85]  J. Faergemann.  Treatment of Pityriasis versicolor with Itraconazole: A Double‐Blind Placebo Controlled Study , 1988, Mycoses.

[86]  H. Degreef,et al.  Pharmacokinetic profile of orally administered itraconazole in human skin. , 1988, Journal of the American Academy of Dermatology.

[87]  R. Baran,et al.  Candida onychomycosis—an evaluation of the role of Candida species in nail disease , 1988, The British journal of dermatology.

[88]  J. Wishart.  The influence of food on the pharmacokinetics of itraconazole in patients with superficial fungal infection. , 1987, Journal of American Academy of Dermatology.

[89]  F. M. Ramos,et al.  Randomized Comparative Clinical Trial of Itraconazole and Selenium Sulfide Shampoo for the Treatment of Pityriasis Versicolor , 1987 .

[90]  H. Degreef,et al.  Itraconazole in the treatment of dermatophytoses: a comparison of two daily dosages. , 1987, Reviews of infectious diseases.

[91]  R. Estrada.  Itraconazole in pityriasis versicolor. , 1987, Reviews of Infectious Diseases.

[92]  V. Schuermans,et al.  Itraconazole in the treatment of human mycoses: review of three years of clinical experience. , 1987, Reviews of infectious diseases.

[93]  J. Schuller,et al.  Itraconazole in the treatment of tinea corporis: a pilot study. , 1987, Reviews of Infectious Diseases.

[94]  E. Difonzo,et al.  [Treatment of dermatophytoses and pityriasis versicolor with itraconazole]. , 1987, Annali dell'Istituto Superiore di Sanità.

[95]  H. Degreef,et al.  Itraconazole, a new orally active antifungal, in the treatment of pityriasis versicolor , 1986, The British journal of dermatology.

[96]  R. Hay,et al.  Partial surgical avulsion of the nail in onychomycosis , 1985, Clinical and experimental dermatology.